Claudia Balotta

Overview

Best Publications

• Local epidemics gone viral: Evolution and diffusion of the Italian HIV-1 recombinant form CRF60_BC

  Alessia Lai;Francesco Roberto Simonetti;Gaetano Brindicci;Annalisa Bergna

  667
  Citations

• Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

  Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö

  568
  Citations

• Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1.

  P. Lusso;F. Cocchi;C. Balotta;P. D. Markham

  393
  Citations

• Transmission of Drug-Resistant HIV-1 Is Stabilizing in Europe

  Jurgen Vercauteren;Annemarie M. J. Wensing;David A. M. C. van de Vijver;Jan Albert

  305
  Citations

• Cytomegalovirus Coinfection Is Associated With an Increased Risk of Severe Non–AIDS-Defining Events in a Large Cohort of HIV-Infected Patients

  Miriam Lichtner;Paola Cicconi;Serena Vita;Alessandro Cozzi-Lepri

  227
  Citations

• Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection.

  d'Arminio Monforte A;Testa L;Adorni F;Chiesa E

  197
  Citations

• Homozygous Δ32 deletion of the Ccr-5 chemokine receptor gene in an Hiv-1-infected patient

  Claudia Balotta;Patrizia Bagnarelli;Michela Violin;Anna Lisa Ridolfo

  194
  Citations

• Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

  L. Marije Hofstra;Nicolas Sauvageot;Jan Albert;Jan Albert;Ivailo Alexiev

  187
  Citations

• HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics

  Ana B. Abecasis;Annemarie M.J. Wensing;Dimitris Paraskevis;Jurgen Vercauteren;Jurgen Vercauteren

  186
  Citations

• Productive infection of CD4+ and CD8+ mature human T cell populations and clones by human herpesvirus 6. Transcriptional down-regulation of CD3.

  P Lusso;M Malnati;A De Maria;C Balotta

  177
  Citations

• Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach

  Dimitrios Paraskevis;Dimitrios Paraskevis;Oliver Pybus;Gkikas Magiorkinis;Angelos Hatzakis

  174
  Citations

• Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages.

  C Balotta;P Lusso;R Crowley;R C Gallo

  162
  Citations

• Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

  Alessandro Cozzi-Lepri;Marc Noguera-Julian;Francesca Di Giallonardo;Rob Schuurman

  159
  Citations

• Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy.

  Michela Violin;Alessandro Cozzi-Lepri;Rossella Velleca;Antonella Vincenti

  148
  Citations

• The impact of transmitted drug resistance on the natural history of HIV infection and response to first-line therapy.

  Pillay D;Bhaskaran K;Jurriaans S;Prins M

  142
  Citations

• Origin and regulation of tumor-associated macrophages: the role of tumor-derived chemotactic factor.

  Alberto Mantovani;Wang Ji Ming;Claudia Balotta;Benomar Abdeljalil

  142
  Citations

• The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes

  David A van de Vijver;Annemarie M J Wensing;Gioacchino Angarano;Birgitta Asjö

  141
  Citations

• Type 1 Cytokine Production and Low Prevalence of Viral Isolation Correlate with Long-Term Nonprogression in HIV Infection

  Mario Clerici;Claudia Balotta;Luca Meroni;Enrica Ferrario

  139
  Citations

• Genomic characterization and phylogenetic analysis of SARS-COV-2 in Italy.

  Gianguglielmo Zehender;Alessia Lai;Annalisa Bergna;Luca Meroni

  138
  Citations

• Susceptibility to PNU-140690 (Tipranavir) of Human Immunodeficiency Virus Type 1 Isolates Derived from Patients with Multidrug Resistance to Other Protease Inhibitors

  S. Rusconi;S. La Seta Catamancio;P. Citterio;S. Kurtagic

  134
  Citations

• Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo.

  Patrizia Bagnarelli;Anna Valenza;Stefano Menzo;Riccardo Sampaolesi

  120
  Citations

• Secondary Mutations in the Protease Region of Human Immunodeficiency Virus and Virologic Failure in Drug-Naive Patients Treated with Protease Inhibitor-Based Therapy

  Carlo F. Perno;Alessandro Cozzi-Lepri;Claudia Balotta;Federica Forbici

  120
  Citations

• Neurological Symptoms during Primary Human Immunodeficiency Virus (HIV) Infection Correlate with High Levels of HIV RNA in Cerebrospinal Fluid

  G. Tambussi;A. Gori;B. Capiluppi;C. Balotta

  117
  Citations

• Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms: data from seroconverters in the CASCADE collaboration from 1987 to 2003.

  Bernard Masquelier;Krishnan Bhaskaran;Deenan Pillay;Robert Gifford

  111
  Citations